Variable | Number of studies | Effect estimate (Risk Ratio) | 95% CI | p.value | Heterogeneity | |||
---|---|---|---|---|---|---|---|---|
Q-Value | p.value | I2 | ||||||
Outcomes | Immediate SFRa (day 1) | 7 | 2.12 | 1.13 to 3.98 | 0.019 | 80.87 |  < 0.001 | 98.58 |
Follow-up SFR a(1–3 month) | 7 | 1.15 | 1.06 to 1.25 | 0.0008 | 26.07 | 0.0002 | 77.63 | |
- | - | Effect estimate (SMDa) | - | - | - | - | - | |
Duration of lithotripsy | 8 | 0.08 | −0.15 to 0.32 | 0.486 | 40.46 |  < 0.001 | 82.48 | |
Postoperative hospitalization | 4 | −0.08 | −0.20 to 0.04 | 0.199 | 1.94 | 0.584 | 0.00 | |
- | - | - | Effect estimate (Risk Ratio) | - | - | - | - | - |
Complications | Fever | 8 | 0.33 | 0.22 to 0.48 |  < 0.001 | 5.76 | 0.567 | 0.00 |
Sepsis | 4 | 0.57 | 0.23 to 1.39 | 0.215 | 1.22 | 0.747 | 0.00 | |
Overalb | 3 | 0.41 | 0.27 to 0.61 |  < 0.001 | 3.30 | 0.192 | 0.00 |